Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings C

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript October 24, 2023 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.22, expectations were $2.19. Operator: Welcome to the Quest Diagnostics Third Quarter 2023 Conference Call. At the request of the company, this call is being recorded. The entire contents of the call, including the […]

Related Keywords

Lewisville , Texas , United States , Dallas , America , Kevin Caliendo , Andrew Brackmann , James Davis , Jim Davis , Sam Samad , Brian Tanquilut , William Blair , Pito Chickering , Ann Hynes , Kieran Ryan , Elizabeth Anderson , David Westenberg , Piper Sandler , Jack Meehan , Patrick Donnelly , Lisa Gill , Erin Wright , Physician Lab Services , Morgan Stanley , Tower Health , Texas Oncology Center , Oncology Center , Revenues For Diagnostic Information Services , Lee Health , Nephron Research , Consumer Health , Northern Light Health , Deutsche Bank , Quest Diagnostics , Drug Administration , Jp Morgan , Medicare Advantage , Sarepta Therapeutics , Haystack Oncology , Diagnostic Information Services , Effective Methods , Birth Control , Biggest Brands In This Space , Tube Niches , Derik De Bruin , Investor Day , New York Presby , Quest Diagnostics Third Quarter , Eastern Time , Tim Davis , Case Business , Health Plan , Compound Annual Growth Rates , Revenue Growth , Health Care Costs ,